ELEVATE IDE Study highlights the Safety and Effectiveness of the ALTOÂ® Abdominal Stent Graft System in One-year Results; Data to Be Presented at 2022 VEITHsymposium
Copyright 2022, Business Wire.
news
2022-10-20 12:00:00

October 20, 2022 08:00 AM Eastern Daylight Time IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held global medical device company dedicated to improving patients' lives by providing disruptive therapies for the interventional treatment of vascular disease, announced that the ELEVATE (Expanding Patient Applicability with Polymer Sealing Ovation ALTO Stent Graft) IDE Study has been published online in the Journal of Vascular Surgery. The study reports the clinical outcomes of the ALTO Abdominal Stent Graft System and highlights the device's safety and effectiveness at one-year post-procedure.
